In fact, stimulating high-glucose-dependent insulin secretion is a much better strategy for treating diabetes, as it is associated with a significantly lower risk of hypoglycemia, a very serious clinical problem in diabetes treatment35. This evidence concerns the gene INS and diabetes mellitus.